GO Capital

Expliseat combines innovation and manufacturing performance in the lightest aircraft seat in the world: the Titanium Seat. At just 4 kg, this seat reduces fuel consumption considerably, resulting in savings of up to $500,000 per plane per year. And with 10 patents, the Titanium Seat also provides passengers with greater comfort and 2 inches more room, thanks to its unique ergonomic design.

Producer of animal food products and recipes intended to serve cats and dogs. The company offers fresh food: chicken, and beef parameters, made by a veterinary nutritionist, providing customers with recipes as per the requirements of pets.

Pubstack is a Paris-based company founded in 2018 that specializes in developing a Software as a Service (SaaS) platform for publishers. The company offers an advertisement monitoring and analytics solution designed to help publishers manage their online promotions effectively. By utilizing modern analytics and automation capabilities, Pubstack enables clients to collect, process, and visualize data related to their advertising activities. This empowers publishers to address complex technical issues at scale, ultimately enhancing their understanding of the factors that influence advertising revenues. Through its platform, Pubstack aims to help publishers maximize the value of their content and improve user experiences.

Horama SAS is a biotechnology company based in Paris, France, established in 2014. It specializes in developing gene therapy products aimed at treating rare ophthalmic diseases, particularly targeting inherited retinal dystrophies and retinopathies. By utilizing recombinant adeno-associated viral vectors, Horama's therapies aim to deliver a functional copy of mutated genes to affected retinal cells. This approach seeks to restore normal cell function, prevent further deterioration of vision, and ultimately improve or restore visual capabilities for patients. The company is positioning itself as a significant player in the ophthalmic gene therapy sector, with the goal of enhancing patient autonomy while also contributing to reduced healthcare costs.

Developer of a data analytics platform intended to better understand the positioning performance of each web page. The company's platform leverages technology to simulate the algorithmic behavior of a search engine when it browses the web and makes it possible to predict and measure the ability of a site to position itself at the highest point in the search engine results in pages, enabling advertisers to better understand their web page performance.

Developer of artificial intelligence-augmented engineering software designed to automate engineer's tasks. The company's platform solves engineering problems based on innovative artificial intelligence from a blank sheet to the detailed design of the different components, enabling automotive and mechanical engineers to increase their profit margins and find totally innovative approaches to engineering challenges.

VitaDX International SA, founded in 2009 and based in Rennes, France, specializes in the early diagnosis of bladder cancer. The company leverages artificial intelligence and fluorescence imaging technology to enhance diagnostic accuracy. Its primary product, VisioCyt®, allows for bladder cancer detection through a simple urine sample, improving upon traditional urinary cytology methods. By utilizing advanced imaging and machine learning techniques, VitaDX's solutions enable pathologists and healthcare providers to identify potential bladder abnormalities early, facilitating timely diagnosis and treatment, which can lead to better patient outcomes.

Acticor Biotech SAS is a biotechnology company based in Paris, France, focused on developing therapeutic monoclonal antibodies for acute thrombotic diseases, particularly ischemic stroke. The company's lead product, Glenzocimab, is a humanized antibody aimed at addressing the critical need for new treatment options in the acute phase of stroke. Stroke affects approximately 15 million people worldwide each year, resulting in significant mortality and disability. Current treatment options are limited, with only one recommended therapy that benefits a small percentage of patients, highlighting the urgent demand for more effective solutions. Acticor Biotech was founded in 2013 and aims to provide innovative therapies that can significantly improve outcomes for stroke patients.

Acticor Biotech SAS is a biotechnology company based in Paris, France, focused on developing therapeutic monoclonal antibodies for acute thrombotic diseases, particularly ischemic stroke. The company's lead product, Glenzocimab, is a humanized antibody aimed at addressing the critical need for new treatment options in the acute phase of stroke. Stroke affects approximately 15 million people worldwide each year, resulting in significant mortality and disability. Current treatment options are limited, with only one recommended therapy that benefits a small percentage of patients, highlighting the urgent demand for more effective solutions. Acticor Biotech was founded in 2013 and aims to provide innovative therapies that can significantly improve outcomes for stroke patients.

TRiCares is a medical device company, devoted to developing a catheter-based valve replacement system for minimal invasive treatment of tricuspid valve regurgitation.

Blacknut SAS, founded in 2016 and headquartered in Cesson-Sévigné, France, specializes in cloud gaming services aimed at consumers and businesses. The company provides a subscription-based platform that features an extensive catalog of over 400 premium video games, suitable for all ages. Blacknut's service is accessible across various devices, including mobile phones, set-top boxes, and Smart TVs, making it available in Europe, Asia, and North America. The platform utilizes an algorithm to tailor game recommendations based on user preferences, facilitating real-time discovery and play. With a focus on user experience, Blacknut aims to revolutionize the distribution of video games while fostering a community for players to share their gaming experiences.

BODYCAP, a young innovative company in the field of medical technologies, based in Hérouville Saint Clair (14), is specialized in the development of miniaturized and communicating electronic sensors for the continuous monitoring of physiological variables of patients. The innovative solutions developed by BODYCAP allow the continuous monitoring of the physiological status of the patient for the purpose of diagnosis, surveillance or clinical investigations within the medical or outpatient structures. These solutions are developed with the aim of improving the patient's comfort and optimizing the data available to the nursing staff.

Seaver SAS is a technology startup based in Caen, France, focused on developing connected girth products for monitoring horse health and performance. Founded in 2016, the company offers innovative devices that track vital metrics such as heart and respiratory rates, calories burned, gait, and jump performance. These connected girths provide real-time data to horse owners and coaches, enhancing their ability to monitor training and overall equine health. Additionally, Seaver has developed a mobile application that complements its hardware by allowing users to access and analyze the data collected from the girth. Through these advancements, Seaver aims to digitalize the equestrian experience, enabling better training outcomes and health management for horses.

Horama SAS is a biotechnology company based in Paris, France, established in 2014. It specializes in developing gene therapy products aimed at treating rare ophthalmic diseases, particularly targeting inherited retinal dystrophies and retinopathies. By utilizing recombinant adeno-associated viral vectors, Horama's therapies aim to deliver a functional copy of mutated genes to affected retinal cells. This approach seeks to restore normal cell function, prevent further deterioration of vision, and ultimately improve or restore visual capabilities for patients. The company is positioning itself as a significant player in the ophthalmic gene therapy sector, with the goal of enhancing patient autonomy while also contributing to reduced healthcare costs.

VitaDX International SA, founded in 2009 and based in Rennes, France, specializes in the early diagnosis of bladder cancer. The company leverages artificial intelligence and fluorescence imaging technology to enhance diagnostic accuracy. Its primary product, VisioCyt®, allows for bladder cancer detection through a simple urine sample, improving upon traditional urinary cytology methods. By utilizing advanced imaging and machine learning techniques, VitaDX's solutions enable pathologists and healthcare providers to identify potential bladder abnormalities early, facilitating timely diagnosis and treatment, which can lead to better patient outcomes.

Alcuin SAS is a software development company specializing in talent and training management solutions. Founded in 2013 and based in Beaucouzé, France, with an additional office in Paris, Alcuin provides a comprehensive range of human capital management services. These include talent assessments, recruitment portals, employee and manager portals, performance reviews, training plan development, and strategic workforce planning. The company serves a diverse clientele across various sectors, including banking, insurance, health, transport, energy, media, and the public sector. In addition to corporate learning management, which encompasses sales management and training portfolio organization, Alcuin also offers campus learning management solutions tailored for educational institutions. This includes program design, admissions, accreditation, and internship management. Alcuin’s software is designed to address the training and human resources management needs of businesses, training organizations, and higher education institutions, both in France and internationally. Alcuin operates as a subsidiary of Total Specific Solutions.

Qowisio SAS is an IoT solution provider based in Angers, France, with additional offices in Austin, Texas, and Paris. Founded in 2009, the company specializes in low-cost, low-power cellular networks for IoT applications, focusing on low-bandwidth connectivity for wireless devices. Qowisio offers a diverse range of connected devices and technological solutions tailored to various use cases, including tracking, power monitoring, environment monitoring, security monitoring, pallet tracking, and temperature monitoring for buildings and commercial refrigerators. Its products are designed to enhance productivity and enable clients, including small to medium-sized businesses and larger enterprises, to create new revenue streams through improved connectivity and data integration.

BODYCAP, a young innovative company in the field of medical technologies, based in Hérouville Saint Clair (14), is specialized in the development of miniaturized and communicating electronic sensors for the continuous monitoring of physiological variables of patients. The innovative solutions developed by BODYCAP allow the continuous monitoring of the physiological status of the patient for the purpose of diagnosis, surveillance or clinical investigations within the medical or outpatient structures. These solutions are developed with the aim of improving the patient's comfort and optimizing the data available to the nursing staff.

BODYCAP, a young innovative company in the field of medical technologies, based in Hérouville Saint Clair (14), is specialized in the development of miniaturized and communicating electronic sensors for the continuous monitoring of physiological variables of patients. The innovative solutions developed by BODYCAP allow the continuous monitoring of the physiological status of the patient for the purpose of diagnosis, surveillance or clinical investigations within the medical or outpatient structures. These solutions are developed with the aim of improving the patient's comfort and optimizing the data available to the nursing staff.

Augure, founded in 2002 in Paris, specializes in influencer marketing software that aids brands and agencies in integrating traditional public relations with modern influencer strategies. The platform is utilized by over 1,000 communication, PR, and public affairs teams daily, enabling them to engage relevant influencers, manage campaigns, and enhance their media presence and reputation across social networks. Augure's data services team complements its software offerings by providing consulting support, helping clients interpret data to refine their influencer marketing approaches. The company operates in Europe and Latin America, serving a diverse clientele that includes major organizations such as Orange, Thales, and Château de Versailles.

Augure, founded in 2002 in Paris, specializes in influencer marketing software that aids brands and agencies in integrating traditional public relations with modern influencer strategies. The platform is utilized by over 1,000 communication, PR, and public affairs teams daily, enabling them to engage relevant influencers, manage campaigns, and enhance their media presence and reputation across social networks. Augure's data services team complements its software offerings by providing consulting support, helping clients interpret data to refine their influencer marketing approaches. The company operates in Europe and Latin America, serving a diverse clientele that includes major organizations such as Orange, Thales, and Château de Versailles.